# A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

> **NCT06321198** · NA · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

## Interventions

- **BIOLOGICAL:** iMSC

## Key facts

- **NCT ID:** NCT06321198
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-10
- **Primary completion:** 2027-03-02
- **Final completion:** 2027-03-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06321198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06321198, "A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06321198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*